Harrow HROW
NASDAQ HROW
$30.96 +0.16 (+0.52%)
As of: Oct 1, 2026 · 3:15 PM EDT

Harrow (HROW) EV to FCF (2020 - 2026)

Updated

Harrow's (HROW) EV to FCF was 300.58 for Q2 2026, down 28.5% from 420.12 a year earlier but up 252.4% from the prior quarter.

Analysis

Harrow (HROW) EV to FCF (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Harrow's EV to FCF came in at 252.36, down 27.2% year-over-year; for FY2025, it was 40.74.

  • By year, EV to FCF came in at 130.57 in FY2023 and 55.04 in FY2021.
  • Five-year quarterly EV to FCF spans a low of 40.74 in Q4 2025 and a high of 2093.40 in Q1 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 85.29 (Q1 2026), 40.74 (Q4 2025) and 103.16 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Harrow 1.15 Bn 828.41 Mn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300.58
Mar 31, 2026 85.29
Dec 31, 2025 40.74
Sep 30, 2025 103.16
Jun 30, 2025 420.12
Mar 31, 2025 2,093.40
Sep 30, 2024 502.84
Mar 31, 2024 61.50
Dec 31, 2023 130.57
Sep 30, 2022 133.90
Jun 30, 2022 123.90
Mar 31, 2022 154.76
Dec 31, 2021 55.04
Sep 30, 2021 41.25
Jun 30, 2021 18.14
Mar 31, 2021 93.37
Mar 31, 2020 233.00
API Access

Harrow EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=HROW&period=max&api_key=YOUR_API_KEY